Bayer working on Phase 3 trials for Finerenone as potential treatment for heart failure, non-diabetes CKD
Chronic Kidney Disease poses a significant challenge globally, especially for patients with type 2 diabetes. Despite available treatments, the progression to kidney failure and associated cardiovascular risks remains a concern. ETHealthworld's Rashmi …